A mathematical analysis of the relationship of cardiac output and heart-lung blood volume to observed circulation time is presented. The theoretic conclusions are substantiated by an experiment in which it is shown that diluting the amount of indicator used prolongs the observed circulation time through the heart and lungs.
A mathematical analysis of the relationship of cardiac output and heart-lung blood volume to observed circulation time is presented. The theoretic conclusions are substantiated by an experiment in which it is shown that diluting the amount of indicator used prolongs the observed circulation time through the heart and lungs. mT HE MEASUREMENT of the circulation time through the heart and lungs is one of the most widely used tests of circulatory efficiency in clinical medicine. Yet, surprisingly, the term is usually poorly defined, and there is certainly considerable disagreement concerning its parameters. As Wig-gers1 points out, circulation time is not the time required for the blood to make a complete circulation, because any given corpuscle has such a wide variety of paths over which to travel as to make such a concept meaningless. With many authors the term "circulation time" seems to imply a measure of the mean velocity of flow of an injected substance from the point of injection to the place of detection. Blum-gart2 in his informative review remarks that velocity of blood flow as such cannot be measured and defines the measurable circulation time as being "the interval of time necessary for the fastest particle of a foreign substance to traverse the shortest available path between the point of injection and the place of detection."
If a given amount of indicator is injected at time To, and the concentration of indicator at the place of detection is plotted against time, then, disregarding recirculation, a curve, as shown in figure 1 , will be obtained. This has been demonstrated by b in their studies on an injection method for the determination of cardiac output. Following Blumgart's definition, the circulation time would be the time interval from the instant of injection (To) to the instant (T1) when the first particle of indicator appears. If the From the Departments of Medicine and Pathology, University of California at Los Angeles, School of Medicine, and Los Angeles County Harbor Hospital, Los Angeles, Calif. 583 time interval measured were the time of mean appearance of the injection mass then the circulation time on this ideal curve would be from To to that point on the curve (T3) when half of the area under the curve was between these two points. However, it would seem that, whether the end point be detected objectively (fluorescein) or subjectively (Decholin), the circulation time is determined neither by the appearance of the first particle of indicator nor by the appearance of half the indicator. Rather it would seem that the circulation time actually observed is the time required for an injected indicator to reach a detectable concentration at the place of detection. If this threshold or minimum detectable concentration be assigned the value (P'), then the observed circulation time is the time interval between the injection (To) and the time (T2) when the concentration (P') is reached. It follows that any discussion of the factors controlling the circulation time must be consistent with this definition.
As mentioned, various parameters have been assigned to circulation time. Wiggers' states that the test gives "only rough information regarding changes in the circulation; indeed, an analysis of where and why changes occurred can generally not be made." However, it is almost universally recognized that as a clinical test the circulation time is useful in both establishing diagnoses and following the course of disease. It becomes prolonged in congestive heart failure and returns toward normal with relief of failure, although it is usually normal or rapid in heart failure due to anemia, thyrotoxicosis, beriberi and arteriovenous fistula. Blumgart2 demonstrated that the circulation time is affected by the cross-sectional area of the pathway traveled, which in turn is a function of the amount of blood in the pulmonary Circulation, Volume V, April 1952 vascular bed and the condition of its vessels. Other things being constant, it can be seen that a widening of the pathway will allow the same volume per unit time to pass at a diminished speed. However, if narrowing of the vascular caliber significantly impedes flow, slowing will occur. Again Blumgart assigns great importance to the relationship of cardiac output and velocity of flow. Increasing minute output increases the rate of flow (and decreases circulation time) if other factors remain the same. Decreasing cardiac output has the opposite effect. Thus in myxedema without heart failure the circulation time is prolonged2'4 in association with a diminished cardiac output. Conversely, circulation time is notoriously rapid in Grave's disease, even with heart failure and dilatation of the vascular bed, both of which would tend to prolong it. This must be due to the marked increase in cardiac output which commonly occurs in hyperthyroidism. In the usual case of congestive heart failure circulation time is prolonged even more than it would be in a case of myxedema with the same reduction in cardiac output, because pulmonary engorgement adds its slowing effect.
Recently Nylin,5' B following David and Bouvrain,7 has emphasized the effect of cardiac dilation on circulation time. He suggests that a dilated, poorly emptying heart will prolong circulation time by a diluting effect, and has published studies in which he has correlated circulation time with heart volume as measured by his x-ray technic. Meneely and Chesnut8 have made a similar study and have found a high degree of correlation between the ratio (transverse diameter of the heart/intrathoracic diameter)3 and circulation time. They admit that Nylin's observations in patients with congestive failure of a prolongation of the taste sensation and a flattening of the red cell dilu-TO Tl T2 Tl' tion curve are correct, but they state that this effect could not substantially delay the arrival of the first portion of the injected indicator. They include in their criticism, as does Altschule,9 the objection that a high degree of correlation does not in itself show a causal relationship and that both cardiac dilation and prolonged circulation time may be dependent on other factors such as diminished cardiac output.
Although this post hoc relationship does not in itself prove a causal connection it would seem that a case can be made for Nylin's thesis. The end point of the circulation time is determined not by the arrival of the first particle but by the arrival of a detectable concentration of indicator at the place of detection. As a consequence of this threshold effect and the fact that the indicator cannot be injected instantaneously, the greater the dilution of the injected substance the longer it will take for the threshold concentration to be reached. In other words, the greater the volume of blood between the points of injection and detection, the more gradual will be the ascent and descent of the rising and falling-off curves of concentration plotted against time and the longer it will take for the threshold concentration (P') to be reached ( fig. 2 ). This effect, rather than laminar flow, probably accounts for the "stringing out" phenomenon which has been discussed in the literature.2 Both the rising and fallingoff curves are, to the extent which they are determined by this factor, exponential. This conclusion is justified by data already in the literature. Nylin's6 10 red corpuscle dilution curves show a more gradual ascent and falling off in patients with congestive failure. Also, it is a well recognized clinical observation that, in patients with congestive failure, the end point of a circulation time determination tends to be diffuse rather than sharp, and the effect builds up gradually and may last longer. Further, Hitzig"1 in his work on ether arm to lung circulation times found that if he made the ether dose small enough there was not only a poorly defined, but also a prolonged end point in normals. The effect of dose on time-concentration is shown schematically in figure 3 when P' is again the minimal detectable concentration.
Other factors affecting circulation time can be discarded or defined in terms of one of the above factors. Blumgart2 assumes that the path traveled is relatively uniform from patient to patient as is shown by the relatively small range of normal circulation times. And certainly laminar flow must be minimal in a system with pulsations, changing frictions, changing diameters, turns and branchings. The viscosity of the blood will be reflected in the cardiac output, dilution and cross-sectional parameters. For example, in anemia the cardiac output increases and the blood volume decreases with a resulting rapid circulation time. Conversely, in polycythemia the cardiac output is normal,'2 but the plethora causes an increase in cross section of the blood channels and a greater dilution of indicator and so the circulation time may be prolonged.2' 12 Diminution of the avail-able cross-sectional area will, after a certain point is reached, impede flow. Other things being equal this effect will be mirrored by a diminution in cardiac output. An additional factor suggesting itself is the relation of the time of injection to the phase of the cardiac and respiratory cycles. Even in a case of complete heart block it is difficult to imagine the phase of the cardiac cycle having an effect of more than a second or so, and moderate increases in respiration are known to have little effect on cardiac output. Breath holding diminishes blood flow in the lungs and should be avoided in performing the test.
Therefore, it would seem that the circulation time, as here defined, is a function of (1) the cross-sectional area of the pulmonary vascular bed (controlled by the volume of blood in the lungs), (2) the cardiac output (itself affected by factors such as peripheral resistance), and (3) the amount of dilution of the injected mass by the blood in the heart and lungs. It can be seen that the blood volume factor affects the observed circulation time in two ways:
(1) the simple linear velocity effect controlled by cross-section, and (2) the exponential delay in reaching a perceptible concentration produced by the diluting pool of blood in the heart and lungs. Referring to figure 1, the linear effect results in the time from To to T, while the exponential or "pool" effect results in the time from T, to T2 where a detectable concentration (P') is reached. If the rise in concentration is steep this second effect will be small. On the other hand, if dilution is great and the ascent of the curve is gradual then the dilution effect will assume importance. The relationship of these various factors can be stated more precisely in mathematical form.
Let VT equal the total volume of blood between the points of injection and detection. This can be considered as the sum of two component volumes, V, and V2. The first, V1, is the blood in the vessels and that portion of the heart's blood that will leave with the following systole. The other volume, V2, is the blood in the lungs plus the portion of the heart's blood not ejected. V2 is the blood making up the "diluting pool."
The linear component, T., of the observed circulation times (To -T1 in fig. 1 ) is a function of the cardiac output (C).
T1V, T= C1
(1) C The rate at which the pool, V2, delivers indicator is a function of the quantity of indicator present in V2. This quantity, Q, is a resultant of two components. (5) and (6) in dP kD-CP dt VV2 (7) This can be integrated into the form T2 = n kD-CP' (8) where T2 is the time from the appearance of the first particle of indicator (T1) until the time (T2) when a detectable concentration (P') is reached.
Then the total observed circulation time is the sum of T1 and T2 or T = V,+ C In kD c C kD -CP' (9) If this exponential effect is significant, then diminishing the amount of indicator used should prolong the observed circulation time as shown in figure 3 . On the other hand, if only the linear relationship holds, changing the dose should not change the circulation time. In order to establish this hypothesis, 33 experiments were performed to study the effect of diminishing the dose of indicator on the observed circulation time.
METHODS
The circulation times were performed with the patients lying as flat in bed as was comfortable with the arm approximately at heart level. No attempt was made to have the patients in a basal state since each experiment served as its own control. The largest vein in the antecubital fossa was selected and 5 ml. of either 10 per cent or 20 per cent Decholin were rapidly injected through an 18 gage needle. An attempt was made to push the plunger into the syringe at the same rate in each injection. The patients were asked to signify both the onset and disappearance of the bitter taste, and times were noted on a stopwatch. After waiting a few minutes the test was again performed, using that concentration of Decholin not used in the first injection. After waiting another few minutes, in 21 cases the first dose was repeated. It was discovered that it made little difference which concentration was used first nor was there any consistent or significant difference in the first and third measurements. Presumably dilution and excretion reduce the blood level of Decholin so rapidly that the remainder after two or three minutes does not form any appreciable increment. Cardiac and intrathoracic diameters were determined from standard 6 foot chest films.
RESULTS
The results are presented in table 1. The taste onset was faster with 20 per cent Decholin than with 10 per cent, and this difference was greater in cardiac patients with failure than in patients without failure. The duration of taste was longer with 20 per cent Decholin, and, DISCUSSION From these preliminary experiments the tentative conclusion is drawn that the "pooling" effect is one of the factors controlling the observed circulation time. Currently a method is being sought for a suitable method for the continuous recording of time-concentration curves following the injection of an indicator. The equation (9) presented probably is not an exact description of the factors controlling circulation time. For example, V1 and V2 are not necessarily distinct quantities, and for the purpose of simplification there is the ad hoc assumption that the time it takes a single rapid particle to traverse the "pool" is very short in comparison with the total circulation time. However, it is thought that the equation gives a good approximate description of the parameters involved. The fair correlation between heart volume and circulation time in this report is only partially in agreement with the work of Meneely and Chesnut.8 However, it must be rememberd that the heart is only a part of the diluting system. The lungs are probably the more important member. Morever, it is likely that the linear component U consumes the major portion of the observed time interval. SUMMARY Circulation time is defined as the time that it takes an injected indicator to reach a detectable concentration at the place of detection. A discussion of the factors affecting circulation time is presented with a mathematical analysis.
By injecting various amounts of indicator it has been shown that "pooling," an exponential parameter previously not well defined, is one of the factors determining circulation time.
